Increased circulating betatrophin concentrations in patients with type 2 diabetes

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Espes, Daniel ^a,b   Martinell, Mats ^a   Carlsson, Per Ola ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETATROPHIN; C PEPTIDE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BETATROPHIN BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIP CIRCUMFERENCE; HORMONE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84902164830     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/323407     Document Type: Article

References (17)

1. Yi P., Park J. S., Melton D. A., Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 2013 153 4 747 758 10.1016/j.cell.2013.04.008
2. Saisho Y., Butler A. E., Manesso E., Elashoff D., Rizza R. A., Butler P. C., β -cell mass and turnover in humans: effects of obesity and aging. Diabetes Care 2013 36 1 111 117
3. Jiao Y., Le Lay J., Yu M., Naji A., Kaestner K. H., Elevated mouse hepatic betatrophin expression does not increase human β -cell replication in the transplant setting. Diabetes 2013 63 4 1283 1288 10.2337/db13-1435
4. Gargani S., Thevenet J., Yuan J. E., Adaptive changes of human islets to an obesogenic environment in the mouse. Diabetologia 2013 56 2 350 358 10.1007/s00125-012-2775-y
5. Tyrberg B., Ustinov J., Otonkoski T., Andersson A., Stimulated endocrine cell proliferation and differentiation in transplanted human pancreatic islets: effects of the ob gene and compensatory growth of the implantation organ. Diabetes 2001 50 2 301 307 2-s2.0-0035143062 (Pubitemid 32127286)
6. Butler A. E., Janson J., Bonner-Weir S., Ritzel R., Rizza R. A., Butler P. C., β -cell deficit and increased β -cell apoptosis in humans with type 2 diabetes. Diabetes 2003 52 1 102 110 2-s2.0-0037219411 10.2337/diabetes.52.1.102 (Pubitemid 36042113)
7. Rahier J., Guiot Y., Goebbels R. M., Sempoux C., Henquin J. C., Pancreatic β -cell mass in European subjects with type 2 diabetes. Diabetes, Obesity and Metabolism 2008 10 supplement 4 32 42 2-s2.0-53549093011 10.1111/j.1463-1326.2008.00969.x
8. Espes D., Lau J., Carlsson P. O., Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 2014 57 1 50 53
9. Levy J. C., Matthews D. R., Hermans M. P., Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 12 2191 2192 2-s2.0-0031737373 (Pubitemid 28549174)
10. Friedrich N., Thuesen B., Jorgensen T., The association between IGF-I and insulin resistance: a general population study in Danish adults. Diabetes Care 2012 35 4 768 773 10.2337/dc11-1833
11. Gautier A., Roussel R., Lange C., Piguel X., Cauchi S., Vol S., Froguel P., Balkau B., Bonnet F., Effects of genetic susceptibility for type 2 diabetes on the evolution of glucose homeostasis traits before and after diabetes diagnosis: data from the D.E.S.I.R. study. Diabetes 2011 60 10 2654 2663 2-s2.0-80053402818 10.2337/db10-1442
12. Inzucchi S. E., Bergenstal R. M., Buse J. B., Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care 2012 35 6 1364 1379 10.2337/dc12-0413
13. Zhang R., Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochemical and Biophysical Research Communications 2012 424 4 786 792 10.1016/j.bbrc.2012.07.038
14. Dong X. Y., Pang X. W., Yu S. T., Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method. International Journal of Cancer 2004 112 2 239 248
15. Ren G., Kim J. Y., Smas C. M., Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. The American Journal of Physiology-Endocrinology and Metabolism 2012 303 3 E334 E351 10.1152/ajpendo.00084.2012
16. Quagliarini F., Wang Y., Kozlitina J., Atypical angiopoietin-like protein that regulates ANGPTL3. Proceedings of the National Academy of Sciences of the United States of America 2012 109 48 19751 19756 10.1073/pnas.1217552109
17. Fenzl A., Itariu B. K., Kosi L., Fritzer-Szekeres M., Kautzky-Willer A., Stulnig T. M., Kiefer F. W., Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 2014 57 6 1204 1208 10.1007/s00125-014-3208-x